Medizone Intl. (fka MZEIQ)

[Tane61]

MZEI: NO U.S. EPA Public Health Antimicrobial Pesticide Product Registration for the Asepticsure System

Expanding on yesterday's SEC filing, Medizone is now able to market & sell AsepticSure as an applicator in the US effective immediately

The U.S. EPA have stated, categorically, that they DO NOT REGULATE "application equipment"


---------------

Again, Medizone has failed to gain U.S. Environmental Protection Agency (EPA) Public Health Antimicrobial Pesticide Product Registration for the AsepticSure System

---------------


January 28, 2011

Joan Harrigan-Farrelly
Director
Antimicrobial Division
Office of Pesticide Programs
U.S Environment Protection Agency

Dear Ms. Harrigan-Farrelly:

On behalf of the Association for Professionals in Infection Prevention (APIC), the Society for Healthcare Epidemiology of America (SHEA) and the Association for the Healthcare Environment (AHE) formerly ASHES, we welcome the opportunity to comment on the topic of fogging applications for disinfectants. The issues are very pertinent to our organizations and we are responding collectively to reinforce our close agreement on mutual concerns, especially worker safety.....When used properly, HP also likely offers a greater margin of safety compared to other chemicals that can also be applied by vapor such as chlorine dioxide or ozone.(Davies A, 2011, in press JHI)

7. Are there any active ingredients that may be problematic for your facility as foggers?

Ingredients that affect OSHA exposure limits that may affect workers, especially agents such as formaldehyde or phenol-based agents, would be a concern. The latter were chemicals that stimulated investigation and ultimately specific recommendations against their use by CDC. Other chemicals such as chlorine dioxide and ozone also have many documented safety issues that would preclude their use in healthcare facilities.(Davies,JHI2011)

---------------

Four (4) plus years after MZEI began discussing AsepticSure with the EPA they have sourced EPA-Registered (conditional) H2O2

---------------

US Environmental Protection Agency Office of Pesticide Programs
Pesticide Registration (PR) Notice 2013-2 Peroxy Compounds Task Force
November 13, 2013

II. The Use of PCTF Data under the Federal Regulatory Scheme

On September 23, 2009, EPA announced the opening of the registration review docket for the active ingredients hydrogen peroxide, peroxyacetic acid and potassium peroxymonosulfate (Peroxy Compounds), as part of the registration review process that pesticide registrations must undergo every 15 years under FIFRA §3(g).3 The agency published a Summary Document on September 23, 2009 containing a Preliminary Work Plan (PWP) for Peroxy Compounds as part of registration review. In March 2010, the Agency issued a Final Work Plan (FWP) that described potential risks to human health and environment from Peroxy Compounds and identified associated expected data needs.

On December 21, 2011, US EPA issued a Data Call-In (DCI) Notice for all Peroxy Compounds under FIFRA § 3(c)(2)(B)4 (“the DCI”). Subsequently, on February 22, 2012, the DCI was withdrawn by the Agency and then the Agency reissued the DCI on February 22, 2012. The DCI imposes new data requirements for Peroxy Compounds, including human toxicity,ecotoxicity, environmental fate, and occupational exposure studies. All registrants who do not purchase an EPA-registered source of peroxy compounds for incorporation into their pesticide products are responsible for satisfying the data requirements identified in the DCI. If a registrant does not satisfactorily address a DCI’s data requirements, the Agency may suspend the registrant’s affected registration(s).

www.epa.gov/sites/production/files/2014-04/documents/pr2013-2.pdf

THE FANTASY WORLD THAT EDWIN G. MARSHALL LIVES IN...


Medizone International Announces Hospital Sterilization Initiative

10/01/2008 @ 8:35AM

PR Newswire (US)

"Mr. Edwin Marshall, Chairman and CEO of Medizone International stated, "With Dr. Shannon's leadership in this exciting new initiative, we anticipate being fully commercialized within 18 months."

-----

TO DATE, NOT ONE (1) SALE TO A HOSPITAL NOR ONE (1) HOSPITAL SERVICE CONTRACT HAS BEEN REPORTED, WORLDWIDE (The manufacture of the first production machine was announced back in April 2012)